A Novel Machine Learning Approach Uncovers New and Distinctive Inhibitors for Cyclin-Dependent Kinase 9
Source check: Needs source check. Not independent scientific confirmation.
Finding / tested result: Two new CDK9 inhibitors were reported, including one structurally distinct hit. Prior research hold is the same case, not an additional discovery; date refers to the supplied preprint.
Technology: Generative and predictive learned molecular models
Publication: Preprint · Test context: direct test. Catalog categories, not an evidence grade.
- AI contribution
- Generative and predictive learned molecular models is the AI method documented in the editorial source review.
- Limitation / still unknown
- The official bioRxiv manuscript was inaccessible in this review. Methods, selected-compound denominator, exact posting date and version-specific results were not authenticated against the original; an author-uploaded reproduction does not resolve those source checks. These access limits do not establish that any scientific finding is absent.
Evidence sources and annotation context
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
Evidence sources: https://doi.org/10.1101/2020.03.18.996538
Needs source check · editorial details
The source has not been fully checked or contains conflicting information. Independent confirmation is not assessed by this label.
Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.
Review date: 18 Nov 2026. Review scope: Official bioRxiv QR/DOI identity metadata identifying v1; an author-uploaded ResearchGate reproduction was consulted but not authenticated against the hosted original. Primary manuscript/API routes were inaccessible; primary Methods and Results were not verified..
No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.
Editorial assessment: Impact 2/5 · Validation 3/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.